The Local Peripheral Antihyperalgesic Effect of Levetiracetam and Its Mechanism of Action in an Inflammatory Pain Model

@article{StepanoviPetrovi2012TheLP,
  title={The Local Peripheral Antihyperalgesic Effect of Levetiracetam and Its Mechanism of Action in an Inflammatory Pain Model},
  author={Radica Stepanovi{\'c}-Petrovi{\'c} and Ana Micov and Maja Tomi{\'c} and Nenad D. Ugre{\vs}i{\'c}},
  journal={Anesthesia \& Analgesia},
  year={2012},
  volume={115},
  pages={1457–1466}
}
BACKGROUND: We have recently shown that levetiracetam, administered systemically, exerts an antihyperalgesic effect in a rat inflammatory pain model. In this study, we examined whether levetiracetam has local peripheral antihyperalgesic/anti-edematous effects in the same model of localized inflammation and whether opioidergic, adrenergic, purinergic, 5-HTergic, and GABAergic receptors are involved in its antihyperalgesic action. METHODS: Rats were intraplantarly (IPL) injected with carrageenan… 

Figures from this paper

Antihyperalgesic/Antinociceptive Effects of Ceftriaxone and Its Synergistic Interactions with Different Analgesics in Inflammatory Pain in Rodents

Results suggest that ceftriaxone, particularly in combinations with ibuprofen, celecoxib, paracetamol, or levetiracetam, may provide useful approach to the clinical treatment of inflammation-related pain.

The Effects of Levetiracetam, Sumatriptan, and Caffeine in a Rat Model of Trigeminal Pain: Interactions in 2-Component Combinations

Results indicate that levetiracetam may be useful for treatment of pain in the trigeminal region and dietary caffeine might decrease the effects of levetIRacetam and sumatriptan; this needs to be considered in clinical settings.

Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model

Combinations of levetiracetam with gabapentin/pregabalin/duloxetine and low-dose aspirin/coenzyme Q10/α-lipoic acid that target underlying causes of DPN, produce marked synergistic interactions in reducing nociception in diabetic mice.

Metformin Synergizes With Conventional and Adjuvant Analgesic Drugs to Reduce Inflammatory Hyperalgesia in Rats

The results suggest that in patients who are already receiving metformin therapy, lower doses of ibuprofen/aspirin/tramadol/pregabalin might be sufficient for achieving satisfactory pain relief.

Adenosine receptor targets for pain

Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain

An overview of the therapeutic potential of ligands interacting with ARs and the adenosinergic system for the treatment of acute and chronic pain is provided.

Brivaracetam attenuates pain behaviors in a murine model of neuropathic pain

The effect of brivaracetam, which binds to synaptic vesicle glycoprotein 2A with 20-fold greater affinity, and has fewer off-target effects, is studied in animal models of neuropathic pain.

References

SHOWING 1-10 OF 44 REFERENCES

The mechanisms of antihyperalgesic effect of topiramate in a rat model of inflammatory hyperalgesia

The results suggest that topiramate produces systemic and local peripheral antihyperalgesia in an inflammatory pain model, which is, at least partially, mediated by central GABAA and opioid receptors and by peripheral and most probably central α2‐adrenergic receptors.

The Involvement of Peripheral α2-Adrenoceptors in the Antihyperalgesic Effect of Oxcarbazepine in a Rat Model of Inflammatory Pain

The results indicate that the peripheral α2A and α2C adrenoceptors could be involved in the antihyperalgesic effects of oxcarbazepine in a rat model of inflammatory hyperalgesia.

GABAergic Mechanisms Are Involved in the Antihyperalgesic Effects of Carbamazepine and Oxcarbazepine in a Rat Model of Inflammatory Hyperalgesia

The results indicate that the antihyperalgesic effects of carbamazepine and oxcarbazepine against inflammatory hyperalgesia involve in part the GABAergic inhibitory modulation of pain transmission at central, but not at peripheral sites, which is mediated via GABAA receptor activation.

Peripheral anti-hyperalgesia by oxcarbazepine: involvement of adenosine A1 receptors.

Results indicate that OXC produces local peripheral anti-hyperalgesic effects, which is mediated via peripheral A1 receptors.

Peripheral antinociception by carbamazepine in an inflammatory mechanical hyperalgesia model in the rat: a new target for carbamazepine?

The results suggest that carbamazepine produces local peripheral anti-hyperalgesia via peripheral adenosine A(1) receptors.

Inhibition of Inflammation-Induced Thermal Hypersensitivity by Sumatriptan through Activation of 5-HT1B/1D Receptors

It is demonstrated that sumatriptan attenuates the hypersensitivity to noxious thermal stimuli induced by intraplantar carrageenan and had no effect on thermal hyperalgesia induced by sciatic nerve ligation in the rat at any time point.

The antihyperalgesic effect of levetiracetam in an inflammatory model of pain in rats: mechanism of action

Investigating the antihyperalgesic effect of levetiracetam and its mechanism of action, by examining the involvement of GABAergic, opioidergic, 5‐hydroxytryptaminergic and adrenergic systems in its effect, in a rat model of inflammatory pain.